|
 |
Rheumoatology |
Antibodies to Extractable Nuclear (ENA)
& Cytoplasmic Antigens
| Code |
Description |
| 040 |
RNP Sm SS-A(Ro) and SS-B(La) |
| 041 |
RNP and Sm |
| 042 |
RNP |
| 043 |
Sm |
| 044 |
SS-A(Ro) & SS-B(La) |
| 045 |
SS-A(Ro) |
| 046 |
SS-B(La) |
| 047 |
Scl-70 |
| 048 |
Jo-1 |
| 050 |
Ku for polymyositis/scleroderma overlap |
| 051 |
PCNA/Cyclin |
| 052 |
PM/Scl for myositis |
| 070 |
CT Profile |
| 071 |
Drug induced LE Profile |
| 077 |
SLE Profile I |
| 078 |
SLE Profile II |
| 079 |
SLE Profile III |
Systemic Lupus Erythematosus (SLE)
| Code |
Description |
| 001 |
ANA titer and pattern on HEp-2 & Mouse kidney |
| 002 |
ANA titer and pattern on HEp-2 only |
| 004 |
Anti-ssDNA antibody titer |
| 005 |
Anti-ssDNA antibody titer |
| 007 |
Anti-Histone Antibodies IgG & IgM |
| 008 |
Anti-Phospholipid/Cardiolipin (APL) antibodies IgG IgM &
Ig |
| 011 |
Rheumatoid Factor (RF) IgM IgA & IgG |
| 012 |
Anti-Ribosomal P antibodies for SLE |
| 013 |
RNA antibodies |
| 055 |
Anti-Beta 2 Glycoprotein (B2GP1) antibody level |
Dermato/Polymyositis
| Code |
Description |
| 049 |
Mi-2 for dermatomyositis |
| 053 |
SRP (Signal Recognition Particle) |
| 072 |
Dermato/Polymyositis Profile |
Relapsing Polychondritis
| Code |
Description |
| 015 |
Collagen Type II antibodies level |
Rheumatoid Arthritis
| Code |
Description |
| 001 |
ANA titer and pattern on HEp-2 & Mouse kidney |
| 009 |
Anti-Keratin Antibodies (AKA) |
| 011 |
Rheumatoid Factor (RF) IgM IgA & IgG |
| 017 |
Anti-CCP IgG |
| 073 |
Rheumatoid Arthritis Profile I (Includes 001, 011, 017) |
| 074 |
Rheumatoid Arthritis Profile II (Includes 001, 009, 011, 017) |
Vasculitis
| Code |
Description |
| 003 |
ANCA - Neutrophil cytoplasmic antibody titer |
| 014 |
Circulating Immune Complexes (CIC) |
| 056 |
Anti-MPO (pANCA) antibody level |
| 057 |
Anti-PR3 (cANCA) antibody level |
| 080 |
Vasculitis Profile |
| 270 |
Anti-GBM (Glomerular basement membrane) antibodies |
|
|
|
